FDA’s Orange Book Dispute Resolution Process May Grow Teeth With FTC Patent Listing Challenges

Dispute book
FTC invokes new use of FDA process to challenge Orange Book patent listings • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics